Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AvePoint (AVPT) Current Deferred Revenue (2019 - 2025)

AvePoint (AVPT) has disclosed Current Deferred Revenue for 7 consecutive years, with $185.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue rose 21.13% to $185.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $185.7 million, a 21.13% increase, with the full-year FY2025 number at $185.7 million, up 21.13% from a year prior.
  • Current Deferred Revenue was $185.7 million for Q4 2025 at AvePoint, up from $159.1 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $185.7 million in Q4 2025 to a low of $73.8 million in Q2 2022.
  • A 5-year average of $119.9 million and a median of $115.6 million in 2023 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: fell 0.53% in 2021, then soared 39.48% in 2023.
  • AvePoint's Current Deferred Revenue stood at $74.3 million in 2021, then soared by 36.61% to $101.5 million in 2022, then rose by 27.4% to $129.3 million in 2023, then increased by 18.57% to $153.3 million in 2024, then increased by 21.13% to $185.7 million in 2025.
  • Per Business Quant, the three most recent readings for AVPT's Current Deferred Revenue are $185.7 million (Q4 2025), $159.1 million (Q3 2025), and $170.2 million (Q2 2025).